Publications

  1. Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 2014 Jan; 27(1):113-27. Epub 2013 Jul 5
    View PubMed
  2. Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Nucci MR, Keeney GL. MD MDM2 amplification in endometrial stromal tumors: a potential diagnostic pitfall. Accepted for publication, 07-03-2015. International Journal of Gynecological Pathology. 2014.
  3. Kelemen K, Galani K, Conley C, Greipp PT. Relapsed acute myeloid leukemia with secondary Philadelphia chromosome and erythophagocytosis after hematopoietic cell transplantation. - In Press - 06-10-2014 Cancer Genetics. 2014.
  4. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol. 2013 Nov; 163(3):326-33. Epub 2013 Aug 27.
    View PubMed
  5. Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC, Kumar S, Greipp PR. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc. 2010 Oct; 85(10):905-12. Epub 2010 Jul 15.
    View PubMed
  6. Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol. 2008 Apr; 141(2):135-48. Epub 2008 Mar 03.
    View PubMed
  7. Greipp PT, Rajkumar V. Bortezomib: effective therapy for multiple myeloma targeting the ubiquitin-proteasome pathway. American Journal of Oncology Review. 2005 Jul; 4(7):468-71.
  8. Greipp PT, Dewald GW, Tefferi A. Prevalence, breakpoint distribution, and clinical correlates of t(5;12). Cancer Genet Cytogenet. 2004 Sep; 153(2):170-2.
    View PubMed